 | • レポートコード：D0GIR-02114 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、予測バイオマーカーの世界市場を広く調査・分析し、今後の市場展望をまとめております。予測バイオマーカーの種類別市場規模（がん、神経障害、心臓血管障害、免疫障害、その他）、用途別市場規模（診断センター、学術研究機関、CRO’S、バイオ医薬品企業）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Siemens Healthcare、Abbott Laboratories、Roche Diagnostic、G.E. Healthcare、Johnson and Johnson、Qiagen ・地域別グローバル市場分析 2015年-2020年 ・予測バイオマーカーの北米市場（アメリカ、カナダ、メキシコ） ・予測バイオマーカーのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・予測バイオマーカーのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・予測バイオマーカーの南米市場（ブラジル、アルゼンチン） ・予測バイオマーカーの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：がん、神経障害、心臓血管障害、免疫障害、その他 ・用途別分析：診断センター、学術研究機関、CRO’S、バイオ医薬品企業 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Predictive Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Predictive Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Predictive Biomarkers market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Predictive Biomarkers market has been segmented into:
Cancer
Neurological Disorder
Cardiovascular Disorder
Immunological Disorder
Others
By Application, Predictive Biomarkers has been segmented into:
Diagnostic Centers
Academic Research Institutes
CRO’S
Bio-Pharmaceutical Companies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Predictive Biomarkers market presented in the report. This section sheds light on the sales growth of different regional and country-level Predictive Biomarkers markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Predictive Biomarkers market.
The report offers in-depth assessment of the growth and other aspects of the Predictive Biomarkers market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Predictive Biomarkers Market Share Analysis
Predictive Biomarkers competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Predictive Biomarkers sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Predictive Biomarkers sales, revenue and market share for each player covered in this report.
The major players covered in Predictive Biomarkers are:
Siemens Healthcare
Abbott Laboratories
Roche Diagnostic
G.E. Healthcare
Johnson and Johnson
Qiagen
Table of Contents
1 Predictive Biomarkers Market Overview
1.1 Product Overview and Scope of Predictive Biomarkers
1.2 Classification of Predictive Biomarkers by Type
1.2.1 Global Predictive Biomarkers Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Predictive Biomarkers Revenue Market Share by Type in 2019
1.2.3 Cancer
1.2.4 Neurological Disorder
1.2.5 Cardiovascular Disorder
1.2.6 Immunological Disorder
1.2.7 Others
1.3 Global Predictive Biomarkers Market by Application
1.3.1 Overview: Global Predictive Biomarkers Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diagnostic Centers
1.3.3 Academic Research Institutes
1.3.4 CRO’S
1.3.5 Bio-Pharmaceutical Companies
1.4 Global Predictive Biomarkers Market by Regions
1.4.1 Global Predictive Biomarkers Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Predictive Biomarkers (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Predictive Biomarkers Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Predictive Biomarkers Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Predictive Biomarkers Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Predictive Biomarkers Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Predictive Biomarkers Status and Prospect (2015-2025)
2 Company Profiles
2.1 Siemens Healthcare
2.1.1 Siemens Healthcare Details
2.1.2 Siemens Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Siemens Healthcare SWOT Analysis
2.1.4 Siemens Healthcare Product and Services
2.1.5 Siemens Healthcare Predictive Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Abbott Laboratories SWOT Analysis
2.2.4 Abbott Laboratories Product and Services
2.2.5 Abbott Laboratories Predictive Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.3 Roche Diagnostic
2.3.1 Roche Diagnostic Details
2.3.2 Roche Diagnostic Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Roche Diagnostic SWOT Analysis
2.3.4 Roche Diagnostic Product and Services
2.3.5 Roche Diagnostic Predictive Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.4 G.E. Healthcare
2.4.1 G.E. Healthcare Details
2.4.2 G.E. Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 G.E. Healthcare SWOT Analysis
2.4.4 G.E. Healthcare Product and Services
2.4.5 G.E. Healthcare Predictive Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson and Johnson
2.5.1 Johnson and Johnson Details
2.5.2 Johnson and Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson and Johnson SWOT Analysis
2.5.4 Johnson and Johnson Product and Services
2.5.5 Johnson and Johnson Predictive Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
2.6 Qiagen
2.6.1 Qiagen Details
2.6.2 Qiagen Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Qiagen SWOT Analysis
2.6.4 Qiagen Product and Services
2.6.5 Qiagen Predictive Biomarkers Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Predictive Biomarkers Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Predictive Biomarkers Players Market Share
3.2.2 Top 10 Predictive Biomarkers Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Predictive Biomarkers Revenue and Market Share by Regions
4.2 North America Predictive Biomarkers Revenue and Growth Rate (2015-2020)
4.3 Europe Predictive Biomarkers Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Predictive Biomarkers Revenue and Growth Rate (2015-2020)
4.5 South America Predictive Biomarkers Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Predictive Biomarkers Revenue and Growth Rate (2015-2020)
5 North America Predictive Biomarkers Revenue by Countries
5.1 North America Predictive Biomarkers Revenue by Countries (2015-2020)
5.2 USA Predictive Biomarkers Revenue and Growth Rate (2015-2020)
5.3 Canada Predictive Biomarkers Revenue and Growth Rate (2015-2020)
5.4 Mexico Predictive Biomarkers Revenue and Growth Rate (2015-2020)
6 Europe Predictive Biomarkers Revenue by Countries
6.1 Europe Predictive Biomarkers Revenue by Countries (2015-2020)
6.2 Germany Predictive Biomarkers Revenue and Growth Rate (2015-2020)
6.3 UK Predictive Biomarkers Revenue and Growth Rate (2015-2020)
6.4 France Predictive Biomarkers Revenue and Growth Rate (2015-2020)
6.5 Russia Predictive Biomarkers Revenue and Growth Rate (2015-2020)
6.6 Italy Predictive Biomarkers Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Predictive Biomarkers Revenue by Countries
7.1 Asia-Pacific Predictive Biomarkers Revenue by Countries (2015-2020)
7.2 China Predictive Biomarkers Revenue and Growth Rate (2015-2020)
7.3 Japan Predictive Biomarkers Revenue and Growth Rate (2015-2020)
7.4 Korea Predictive Biomarkers Revenue and Growth Rate (2015-2020)
7.5 India Predictive Biomarkers Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Predictive Biomarkers Revenue and Growth Rate (2015-2020)
8 South America Predictive Biomarkers Revenue by Countries
8.1 South America Predictive Biomarkers Revenue by Countries (2015-2020)
8.2 Brazil Predictive Biomarkers Revenue and Growth Rate (2015-2020)
8.3 Argentina Predictive Biomarkers Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Predictive Biomarkers by Countries
9.1 Middle East & Africa Predictive Biomarkers Revenue by Countries (2015-2020)
9.2 Saudi Arabia Predictive Biomarkers Revenue and Growth Rate (2015-2020)
9.3 UAE Predictive Biomarkers Revenue and Growth Rate (2015-2020)
9.4 Egypt Predictive Biomarkers Revenue and Growth Rate (2015-2020)
9.5 South Africa Predictive Biomarkers Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Predictive Biomarkers Revenue and Market Share by Type (2015-2020)
10.2 Global Predictive Biomarkers Market Forecast by Type (2019-2024)
10.3 Cancer Revenue Growth Rate (2015-2025)
10.4 Neurological Disorder Revenue Growth Rate (2015-2025)
10.5 Cardiovascular Disorder Revenue Growth Rate (2015-2025)
10.6 Immunological Disorder Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Predictive Biomarkers Market Segment by Application
11.1 Global Predictive Biomarkers Revenue Market Share by Application (2015-2020)
11.2 Predictive Biomarkers Market Forecast by Application (2019-2024)
11.3 Diagnostic Centers Revenue Growth (2015-2020)
11.4 Academic Research Institutes Revenue Growth (2015-2020)
11.5 CRO’S Revenue Growth (2015-2020)
11.6 Bio-Pharmaceutical Companies Revenue Growth (2015-2020)
12 Global Predictive Biomarkers Market Size Forecast (2021-2025)
12.1 Global Predictive Biomarkers Market Size Forecast (2021-2025)
12.2 Global Predictive Biomarkers Market Forecast by Regions (2021-2025)
12.3 North America Predictive Biomarkers Revenue Market Forecast (2021-2025)
12.4 Europe Predictive Biomarkers Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Predictive Biomarkers Revenue Market Forecast (2021-2025)
12.6 South America Predictive Biomarkers Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Predictive Biomarkers Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Predictive Biomarkers Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Predictive Biomarkers by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Predictive Biomarkers Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Predictive Biomarkers Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Siemens Healthcare Corporate Information, Location and Competitors
Table 6. Siemens Healthcare Predictive Biomarkers Major Business
Table 7. Siemens Healthcare Predictive Biomarkers Total Revenue (USD Million) (2017-2018)
Table 8. Siemens Healthcare SWOT Analysis
Table 9. Siemens Healthcare Predictive Biomarkers Product and Solutions
Table 10. Siemens Healthcare Predictive Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Abbott Laboratories Corporate Information, Location and Competitors
Table 12. Abbott Laboratories Predictive Biomarkers Major Business
Table 13. Abbott Laboratories Predictive Biomarkers Total Revenue (USD Million) (2018-2019)
Table 14. Abbott Laboratories SWOT Analysis
Table 15. Abbott Laboratories Predictive Biomarkers Product and Solutions
Table 16. Abbott Laboratories Predictive Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Roche Diagnostic Corporate Information, Location and Competitors
Table 18. Roche Diagnostic Predictive Biomarkers Major Business
Table 19. Roche Diagnostic Predictive Biomarkers Total Revenue (USD Million) (2017-2018)
Table 20. Roche Diagnostic SWOT Analysis
Table 21. Roche Diagnostic Predictive Biomarkers Product and Solutions
Table 22. Roche Diagnostic Predictive Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. G.E. Healthcare Corporate Information, Location and Competitors
Table 24. G.E. Healthcare Predictive Biomarkers Major Business
Table 25. G.E. Healthcare Predictive Biomarkers Total Revenue (USD Million) (2017-2018)
Table 26. G.E. Healthcare SWOT Analysis
Table 27. G.E. Healthcare Predictive Biomarkers Product and Solutions
Table 28. G.E. Healthcare Predictive Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Johnson and Johnson Corporate Information, Location and Competitors
Table 30. Johnson and Johnson Predictive Biomarkers Major Business
Table 31. Johnson and Johnson Predictive Biomarkers Total Revenue (USD Million) (2017-2018)
Table 32. Johnson and Johnson SWOT Analysis
Table 33. Johnson and Johnson Predictive Biomarkers Product and Solutions
Table 34. Johnson and Johnson Predictive Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Qiagen Corporate Information, Location and Competitors
Table 36. Qiagen Predictive Biomarkers Major Business
Table 37. Qiagen Predictive Biomarkers Total Revenue (USD Million) (2017-2018)
Table 38. Qiagen SWOT Analysis
Table 39. Qiagen Predictive Biomarkers Product and Solutions
Table 40. Qiagen Predictive Biomarkers Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Global Predictive Biomarkers Revenue (Million USD) by Players (2015-2020)
Table 42. Global Predictive Biomarkers Revenue Share by Players (2015-2020)
Table 43. Global Predictive Biomarkers Revenue (Million USD) by Regions (2015-2020)
Table 44. Global Predictive Biomarkers Revenue Market Share by Regions (2015-2020)
Table 45. North America Predictive Biomarkers Revenue by Countries (2015-2020)
Table 46. North America Predictive Biomarkers Revenue Market Share by Countries (2015-2020)
Table 47. Europe Predictive Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 48. Asia-Pacific Predictive Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 49. South America Predictive Biomarkers Revenue by Countries (2015-2020)
Table 50. South America Predictive Biomarkers Revenue Market Share by Countries (2015-2020)
Table 51. Middle East and Africa Predictive Biomarkers Revenue (Million USD) by Countries (2015-2020)
Table 52. Middle East and Africa Predictive Biomarkers Revenue Market Share by Countries (2015-2020)
Table 53. Global Predictive Biomarkers Revenue (Million USD) by Type (2015-2020)
Table 54. Global Predictive Biomarkers Revenue Share by Type (2015-2020)
Table 55. Global Predictive Biomarkers Revenue Forecast by Type (2021-2025)
Table 56. Global Predictive Biomarkers Revenue by Application (2015-2020)
Table 57. Global Predictive Biomarkers Revenue Share by Application (2015-2020)
Table 58. Global Predictive Biomarkers Revenue Forecast by Application (2021-2025)
Table 59. Global Predictive Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Predictive Biomarkers Picture
Figure 2. Global Predictive Biomarkers Revenue Market Share by Type in 2019
Figure 3. Cancer Picture
Figure 4. Neurological Disorder Picture
Figure 5. Cardiovascular Disorder Picture
Figure 6. Immunological Disorder Picture
Figure 7. Others Picture
Figure 8. Predictive Biomarkers Revenue Market Share by Application in 2019
Figure 9. Diagnostic Centers Picture
Figure 10. Academic Research Institutes Picture
Figure 11. CRO’S Picture
Figure 12. Bio-Pharmaceutical Companies Picture
Figure 13. Global Predictive Biomarkers Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Predictive Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Predictive Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Predictive Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Predictive Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Predictive Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Predictive Biomarkers Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Predictive Biomarkers Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Predictive Biomarkers Revenue Market Share in 2019
Figure 22. Global Top 10 Players Predictive Biomarkers Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Predictive Biomarkers Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Predictive Biomarkers Revenue Market Share by Regions (2015-2020)
Figure 26. Global Predictive Biomarkers Revenue Market Share by Regions in 2018
Figure 27. North America Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 28. Europe Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 30. South America Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 32. North America Predictive Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 33. North America Predictive Biomarkers Revenue Market Share by Countries in 2019
Figure 34. USA Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 35. Canada Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 37. Europe Predictive Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Predictive Biomarkers Revenue Market Share by Countries in 2019
Figure 39. Germany Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 40. UK Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 41. France Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 42. Russia Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 43. Italy Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Predictive Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Predictive Biomarkers Revenue Market Share by Countries in 2019
Figure 46. China Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 47. Japan Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 48. Korea Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 49. India Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 51. South America Predictive Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 52. South America Predictive Biomarkers Revenue Market Share by Countries in 2019
Figure 53. Brazil Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Predictive Biomarkers Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Predictive Biomarkers Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 58. UAE Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Predictive Biomarkers Revenue and Growth Rate (2015-2020)
Figure 61. Global Predictive Biomarkers Revenue Share by Type (2015-2020)
Figure 62. Global Predictive Biomarkers Revenue Share by Type in 2019
Figure 63. Global Predictive Biomarkers Market Share Forecast by Type (2021-2025)
Figure 64. Global Cancer Revenue Growth Rate (2015-2020)
Figure 65. Global Neurological Disorder Revenue Growth Rate (2015-2020)
Figure 66. Global Cardiovascular Disorder Revenue Growth Rate (2015-2020)
Figure 67. Global Immunological Disorder Revenue Growth Rate (2015-2020)
Figure 68. Global Others Revenue Growth Rate (2015-2020)
Figure 69. Global Predictive Biomarkers Revenue Share by Application (2015-2020)
Figure 70. Global Predictive Biomarkers Revenue Share by Application in 2019
Figure 71. Global Predictive Biomarkers Market Share Forecast by Application (2021-2025)
Figure 72. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 73. Global Academic Research Institutes Revenue Growth Rate (2015-2020)
Figure 74. Global CRO’S Revenue Growth Rate (2015-2020)
Figure 75. Global Bio-Pharmaceutical Companies Revenue Growth Rate (2015-2020)
Figure 76. Global Predictive Biomarkers Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Predictive Biomarkers Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Predictive Biomarkers Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Predictive Biomarkers Revenue Market Forecast (2021-2025)
Figure 80. Europe Predictive Biomarkers Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Predictive Biomarkers Revenue Market Forecast (2021-2025)
Figure 82. South America Predictive Biomarkers Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Predictive Biomarkers Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
臨床バイオマーカーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Clinical Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…- 非侵襲的がんバイオマーカーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Noninvasive Cancer Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Noninvasive Can…
- 血清がんバイオマーカーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Serum Cancer Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Serum Cancer Biomarke…
- PARP阻害剤バイオマーカーサービスの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The PARP Inhibitor Biomarkers Service market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 医療バイオマーカーの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Medical Biomarkers market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…